|
|
||||||||
Correspondence to:
W. Pruzanski
In the acute-phase response and in diseases with prolonged acute phases, normal HDL (NHDL) is converted into acute-phase HDL (APHDL) and becomes proinflammatory and unable to protect LDL against oxidative modification. Earlier work had demonstrated that these changes are associated with alterations in apolipoprotein composition and enzymatic activity of APHDL, but the effect of the acute-phase condition on the lipid composition of APHDL had remained obscure. The present study shows marked quantitative differences in lipid composition between NHDL and APHDL. Specifically, APHDL contained 25% less total lipid per milligram of protein. Up to 50% of cholesteryl ester in the lipid core of APHDL was replaced by triacylglycerol; however, the total phospholipid/total neutral lipid ratios were the same as in NHDL, both lipoproteins giving similar calculated lipid core radii. Furthermore, the phosphatidylcholine/sphingomyelin ratio in APHDL was nearly double that in NHDL, indicating a relative loss of sphingomyelin. A decrease was also seen in diacyl and alkenylacyl glycerophosphatidylethanolamine as well as in phosphatidylinositol of APHDL when compared with NHDL. APHDL contained proportionally more saturated and less polyunsaturated and isoprostane-containing species of phosphatidylcholine, as well as more saturated than unsaturated cholesteryl esters. APHDL also contained significantly more free fatty acids, lysophosphatidylcholine, and free cholesterol.
These changes in the lipid composition of HDL are consistent with the alterations in the apoprotein composition and enzymatic activity of APHDL and indicate proinflammatory and proatherogenic roles for APHDL.Pruzanski, W., E. Stefanski, F. C. de Beer, M. C. de Beer, A. Ravandi, and A. Kuksis. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res. 2000. 41: 10351047.
Supplementary key words:
normal and acute phase, high density lipoprotein, lipid composition, functional impact
Copyright © 2000 by Lipid Research, Inc.
Original Article
Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins
W. Pruzanskia,
E. Stefanskia,
F. C. de Beerc,
M. C. de Beerc,
A. Ravandib, and
A. Kuksisb
a Inflammation Research Group, University of Toronto, Toronto, Canada M4Y 1J3
b Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada M4Y 1J3
c Veterans Affairs Medical Center, Lexington, KY 40536
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. I. van Leuven, R. Hezemans, J. H. Levels, S. Snoek, P. C. Stokkers, G. K. Hovingh, J. J. P. Kastelein, E. S. Stroes, E. de Groot, and D. W. Hommes Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease J. Lipid Res., December 1, 2007; 48(12): 2640 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Han, T. Chiba, J. S. Campbell, N. Fausto, M. Chaisson, G. Orasanu, J. Plutzky, and A. Chait Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine Hepatocytes Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1806 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aspichueta, B. Perez-Agote, S. Perez, B. Ochoa, and O. Fresnedo Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver Innate Immunity, June 1, 2006; 12(3): 181 - 191. [Abstract] [PDF] |
||||
![]() |
P. Aspichueta, S. Perez, B. Ochoa, and O. Fresnedo Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver J. Lipid Res., May 1, 2005; 46(5): 1017 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kaysen and J. P. Eiserich The Role of Oxidative Stress-Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction J. Am. Soc. Nephrol., March 1, 2004; 15(3): 538 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Hudgins, T. S. Parker, D. M. Levine, B. R. Gordon, S. D. Saal, X.-c. Jiang, C. E. Seidman, J. D. Tremaroli, J. Lai, and A. L. Rubin A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers J. Lipid Res., August 1, 2003; 44(8): 1489 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tiemeier, H R. van Tuijl, A. Hofman, A. J Kiliaan, and M. M. Breteler Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study Am. J. Clinical Nutrition, July 1, 2003; 78(1): 40 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liebisch, W. Drobnik, B. Lieser, and G. Schmitz High-Throughput Quantification of Lysophosphatidylcholine by Electrospray Ionization Tandem Mass Spectrometry Clin. Chem., December 1, 2002; 48(12): 2217 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Petrovic, C. Grove, P. E. Langton, N. L. A. Misso, and P. J. Thompson A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins J. Lipid Res., October 1, 2001; 42(10): 1706 - 1714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |